ReviewFrontiers in medicine2025
Photoprotection in pregnancy: addressing safety concerns and optimizing skin health.
Review in Frontiers in medicine, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
3 citing papers in PubMed.
- Assessment of Knowledge, Attitudes, Practices and Perceptions Regarding the Use of Sunscreen Among Pharmacists in Jordan.Skin research and technology : official journal of International Society for Bioengineering and the Skin (ISBS) [and] International Society for Digital Imaging of Skin (ISDIS) [and] International Society for Skin Imaging (ISSI) · 2026Article
- Article
- Melanoma in Women of Reproductive Age: From Awareness and Prevention to Pregnancy-Associated Management.Cancers · 2025Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Pregnancy is associated with physiological skin changes, altered response to UV exposure and increased risk of pigmentary disorders such as melasma and linea nigra, which can impact quality of life. This review explores the effects of photoprotection during pregnancy, focusing on safety, efficacy, and the role of sunscreens in preventing pregnancy-associated hyperpigmentation and UV-induced skin damage. Sunscreen use in pregnant women is generally low, despite evidence supporting the benefits of broad-spectrum sunscreens to mitigate pigmentation changes and prevent DNA damage from UV exposure. Physiological changes during pregnancy influence sunscreen selection; ideally, sunscreens should be mineral-based, cosmetically acceptable, potentially supplemented with safe organic filters to optimize cosmetic acceptability and adherence, and free from ingredients associated with potential risks during pregnancy. Tinted sunscreens, which provide protection against high-energy visible light (HEVL), may offer enhanced prevention of hyperpigmentary disorders, and are recommended due to their added camouflage benefits, though shade options should ideally match diverse skin tones. Photoprotection strategy should include the use of wide-brimmed hats, sun-safe clothing and regular use of high-SPF, broad-spectrum sunscreens that protect against UVB, UVA, and HEVL. Tinted, mineral-based formulations potentially supplemented with safe organic filters may be optimal for pregnant women providing both effective protection and cosmetic benefits.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.